Vchal / Shutterstock.com
In its suit, filed at the US District Court for the District of Delaware on Thursday, September 26, PGI accused Pacific Biosciences of infringing US patent 7,767,441 through the sale of its nucleic acid sequencing platform Sequel System.
If you have already subscribed please login.
If you have any technical issues please email tech support.
Pacific Biosciences, genetics, genetic sequencing, Personal Genomics Taiwan, patent infringement, illumina, gene-sequencing